Cost-utility of treatment of bulimia nervosa
Version of Record online: 5 OCT 2009
Copyright © 2009 Wiley Periodicals, Inc.
International Journal of Eating Disorders
Volume 43, Issue 7, pages 596–602, 1 November 2010
How to Cite
Pohjolainen, V., Räsänen, P., Roine, R. P., Sintonen, H., Wahlbeck, K. and Karlsson, H. (2010), Cost-utility of treatment of bulimia nervosa. Int. J. Eat. Disord., 43: 596–602. doi: 10.1002/eat.20754
- Issue online: 5 OCT 2009
- Version of Record online: 5 OCT 2009
- Manuscript Accepted: 29 JUL 2009
- The Hospital Group of Helsinki and Uusimaa
- The Research School of Psychiatry
- The Signe and Ane Gyllenberg Foundation
- bulimia nervosa;
- health related quality of life;
- cost of QALY
The costs of treating eating disorders are high. Our objective was to perform a cost-utility analysis of treatment of bulimia nervosa.
72 patients entering treatment of bulimia nervosa (ICD-10 diagnosis) completed the 15D health-related quality of life (HRQoL) questionnaire and the Eating Disorder Inventory (EDI) before and 6 months after the start of treatment. Quality-adjusted life years (QALYs) gained were calculated and cost-utility was assessed within the time horizon of 10 years.
Baseline HRQoL was severely impaired in the patients. As a consequence of treatment, mean HRQoL improved clinically and statistically significantly. The cost per QALY gained varied from €1,455 to €16,481 (from €4,428 to €19,663 discounted at 5%) depending on the assumptions used in the analysis.
HRQoL of bulimia nervosa patients is severely impaired, but treatment has a clear positive effect on HRQoL. The cost per QALY gained is comparable to many other treatments. © 2009 by Wiley Periodicals, Inc. (Int J Eat Disord 2010;)